◆ 会议时间:2025年9月10-13日
◆ 会议简介: 2025年国际头痛大会(IHC2025)将于2025年9月10-13日在巴西圣保罗举行,本次会议由国际头痛学会(IHS)组织。国际头痛大会(IHC)每两年举行一次。IHC将为与会者提供头痛和偏头痛领域的最新治疗、发展和研究成果,大会致力于加强教育,提高认识,以改善全世界头痛疾病患者的生活。大会组委会邀请前来您分享您的知识,并了解有关头痛治疗的最新进展。 国际头痛学会(IHS)成立于1981年,是世界领先的致力于为遭受头痛困扰的人们提供专业的服务会员制组织。作为一个慈善机构,IHS的目的是宣推进头疼科学、教育和管理的发展,促进全世界对头痛的认识。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com) International Headache Congress (IHC) 2025 Dates: 10-13 September 2025 Orgznized by: International Headache Society The International Headache Congress (IHC) is held every second year. The venue is selected by the IHS Board of Trustees in consultation with a Professional Congress Organiser. As an international society, the aim is to hold congresses worldwide, taking into consideration delegate and sponsor appeal.
摘要征文投稿:
点此提交摘要>>>Submit Abstract>>>
ABSTRACT TOPICSAbstracts are accepted under the following topics.
GENERAL
DEFINITIONS
PUBLICATION AND EMBARGOAll abstracts accepted for IHC 2025 will be published in the following places:
All abstracts accepted for IHC 2025 will be under embargo until 09:00 (Brasilia time) on the morning of Wednesday 10 September 2025 RULESFailure to observe these guidelines may result in disqualification. 1. An abstract can be submitted to the IHC 2025 if it has been presented or published at a national meeting, however this must be stated during submission. Submissions presented at international Congresses previously will not be accepted. In addition to this, the abstract results must not have been previously published within a journal. 2. The correct topic must be selected to ensure correct scoring. The content of the abstract must be topic related. The Scientific Committee reserve the right to re-categorise an abstract. 3. Abstracts must contain data and meet international ethical standards. 4. Abbreviations should be defined. 5. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text. 6. An abstract cannot be accepted if the conflict of interest disclosure has not been completed on the submission form. If the presenter or one of the co-authors has a conflict of interest, this must be clearly stated. Accurate disclosures are the authors’ responsibility. 7. The abstract cannot contain more than 2,500 characters (approx.700 words) – blank spaces, punctuation, author names, affiliations and titles are included in the character count. The title must contain a minimum of 20 characters and maximum of 300 characters. 8. The abstract must be structured into the following sections: Objective; Methods; Results; Conclusion 9. One table can be included, with the following restrictions: Max number of columns: 10 10. Please note that tables may significantly reduce the number of available characters. 11. One figure can be included – this will not be included in the word count. 12. If you have successfully submitted your abstract, you will receive a confirmation number. If no confirmation number is received, the abstract cannot be considered as successfully submitted and accepted. 13. Abstracts fulfilling all criteria can be saved in “FINAL SUBMISSION” status. Only abstracts in “FINAL SUBMISSION” status will be considered as successfully submitted and accepted. 14. If you leave the system without saving the abstract all data is lost. The submitted/draft abstracts cannot be edited after the submission deadline (Monday, 05 May 2025, 23:59 Brasilia time). 15. Please ensure that your abstract does not contain spelling, grammatical or scientific errors. No corrections are possible after the submission deadline. The abstract will be reproduced exactly as submitted. No proof reading will be completed. 16. If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to camila.mazotti@ccmgroup.com.br – no later than 23 May 2025.
*To register for the courses, you must be registered/confirmed for the Congress. The registration must be done within your Congress participant area on the website, under the “additional registration” tab. |
,
© 版权声明
本文由分享者转载或发布,内容仅供学习和交流,版权归原文作者所有。如有侵权,请留言联系更正或删除。
相关文章
暂无评论...